Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00469742 · ClinicalTrials.gov registry record

Aprotinin in Neonates Undergoing Cardiopulmonary Bypass

A clinical trial of Cardiopulmonary Bypass and Hemostasis, sponsored by Children's Healthcare of Atlanta.

Completed
Registry status
290
Enrollment target
1
Study location

NCT00469742 is a study of Cardiopulmonary Bypass and Hemostasis that has completed, run by Children's Healthcare of Atlanta. The registered enrollment target is 290 participants, below the 712-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00469742, a study of Cardiopulmonary Bypass and Hemostasis, has completed, sponsored by Children's Healthcare of Atlanta.

COMPLETED
Registry status
290 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 290 participants
Start Date 2007-04
Est. Completion 2008-12

Sponsor

Children's Healthcare of Atlanta

80 total trials

What the Registry Record Tells You About NCT00469742

The ClinicalTrials.gov registry entry for NCT00469742 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 290 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 712-participant average among 9 other Cardiopulmonary Bypass trials with a reported enrollment target (59% lower). The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cardiopulmonary Bypass appearing as the primary indexed condition, and to 0 interventions.

NCT00469742 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT00469742 about?

NCT00469742 is a clinical study titled "Aprotinin in Neonates Undergoing Cardiopulmonary Bypass". This is a retrospective chart review study. The purpose of this study is to review our experience at Children's Healthcare of Atlanta in neonates receiving aprotinin. We will examine the specific outcomes of renal dysfunction, thrombosis and mortality.

What is the current status of trial NCT00469742?

This trial is currently completed. The enrollment target is 290 participants. The study started on 2007-04. Estimated completion is 2008-12.

What conditions does trial NCT00469742 study?

This clinical trial studies the following conditions: Cardiopulmonary Bypass, Hemostasis, Congenital Defects.

Who is sponsoring clinical trial NCT00469742?

This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00469742 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiopulmonary Bypass

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.